BEIJING, Dec. 16, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has signed on three Romanian companies to distribute Dehaier's DHR-5L oxygen concentrators in Romania. This marks Dehaier's first entry into the European homecare medical product market.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO )

Ms. Rayna Dong, Director of Dehaier's International Business Department said, "We are delighted to establish cooperation with our new distributors in Europe. To extend Dehaier's market reach, our international sales forces have actively sought distribution and OEM opportunities and have participated in international medical equipment trade shows. These activities also promote our market acceptance and brand awareness outside China. We believe that our homecare medical products, such as our full line of sleep-disordered breathing and respiratory products, are not only competitive in terms of quality and price, but also provide all-in-one solution to our end users. Going forward, we will continue to seek distributors to penetrate international markets."

"Our partnership with those distributors in Europe will allow Dehaier to extend its footprint into Europe and marks a significant milestone forward in our international market development plan," commented Mr. Ping Chen, Chief Executive Officer of Dehaier Medical. "We believe that the market potential for our homecare medical products is well beyond the Chinese domestic market. In the coming years, we will continue developing the European and other international markets. As we pursue regulatory approvals in Europe and the United States for more of our products, we aim to sign on more international distributors to reach a wider global market."

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on five patents and five software copyrights; additionally Dehaier has three pending patents, six pending software copyrights and proprietary technology. More information may be found at http://www.chinadhr.com.

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular statements about Dehaier's international growth plans and prospects, future acceptance of its products in China and abroad, receipt of regulatory approvals for Dehaier's products and results of relationships with distributors. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Contact Us

Dehaier Medical Systems Limited

Surie Liu

+86 10-5166-0080

lius@dehaier.com.cn

Dehaier Medical Systems Limited

Lisa Zhou

+86 10-5166-0080

zhouyj@dehaier.com.cn

SOURCE Dehaier Medical Systems Ltd.

Copyright 2011 PR Newswire

Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Lianluo Smart Charts.
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Lianluo Smart Charts.